( October 27, 2026, 12:37 PM EDT) -- BOSTON — A First Circuit U.S. Court of Appeals panel affirmed a lower court’s denial of an investment firm’s motion for leave to amend its complaint stemming from a biopharmaceutical company’s rights agreement because the firm waited for the outcome of related litigation before asserting a theory that could have been pleaded earlier....